What Chronic Lymphocytic Leukemia Patients Should Know about Richter Syndrome with Erin Parry, MD, PhD

Dr. Parry attended Johns Hopkins University School of Medicine where she earned an MD and a PhD. Upon graduation from medical school, Dr. Parry completed residency training in internal medicine at the Johns Hopkins Hospital followed by medical oncology fellowship at Dana-Farber/Partners CancerCare. During her fellowship, Dr. Parry conducted post-doctoral research in the laboratory of Dr. Catherine Wu on Richter transformation of chronic lymphocytic leukemia (CLL). Dr. Parry is currently an Assistant Professor of Medicine at Harvard Medical School and a Physician at Dana-Farber Cancer Institute in the Lymphoma Program and the Center for Chronic Lymphocytic Lymphoma. She runs a laboratory focused on the transformation of indolent B cell malignancies to aggressive lymphoma and mechanisms of immune evasion in CLL and B cell  lymphoma.

Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.